Abstract
Rationale
An increasing number of herbal products has been introduced to treat anxiety and depression. Gelsemium elegans Benth (G. elegans) is a well-known herbal plant in Asia. Four major alkaloids (gelsemine, koumine, gelsevirine, and gelsenicine) have been isolated from G. elegans. Recently, interest has arisen to investigate the pharmaceutical potential of G. elegans alkaloids in the context of neuropsychopharmacology.
Objectives
We investigated whether G. elegans alkaloids are capable of producing anxiolytic and antidepressant effects in mouse models. In particular, we examined whether the anxiolytic action of G. elegans alkaloids is due to the agonist effects of glycine receptor in the brain.
Methods
Two mouse models (elevated plus-maze and light–dark transition model) were used to examine potential anxiolytic effects. Forced swim test and tail suspension test were used to test the antidepressive action of G. elegans alkaloids. Moreover, we also explored the anxiolytic mechanisms of G. elegans alkaloids by intracerebroventricular administration of strychnine, an antagonist of glycine receptor, in the elevated plus-maze.
Results
Gelsemine, koumine, and gelsevirine, but not gelsenicine, exhibited potent anxiolytic effects in the two anxiety models. None of the four G. elegans alkaloids exerted antidepressant effects in the two depression models. None of G. elegans alkaloids impaired spontaneous motor activities. The intracerebroventricular administration of strychnine significantly antagonized the anxiolytic effects of gelsemine, koumine, and gelsevirine administrated subcutaneously.
Conclusions
Gelsemine, koumine, and gelsevirine could be developed as the treatment of anxiety-related disorders in human patients. Their anxiolytic mechanism may be involved in the agonist action of glycine receptor in the brain.
Similar content being viewed by others
Abbreviations
- aCSF:
-
Artificial cerebrospinal fluid
- ANOVA:
-
One-way analysis of variance
- CCC:
-
Counter-current chromatography
- DZP:
-
Diazepam
- EPM:
-
Elevated plus-maze
- FLU:
-
Fluoxetine
- FST:
-
Forced swim test
- GABAA :
-
Gamma aminobutyric acid A receptor
- G. elegans :
-
Gelsemium elegans Benth
- Gly-R:
-
Glycine receptor
- GM:
-
Gelsemine
- G. sempervirens :
-
Gelsemium sempervirens Ait
- GS:
-
Gelsenicine
- GV:
-
Gelsevirine
- HSCCC:
-
High-speed counter-current chromatography
- i.c.v.:
-
Intracerebroventricular
- i.p.:
-
Intraperitoneal
- KM:
-
Koumine
- LDTM:
-
Light–dark transition model
- LD50 :
-
Median lethal dose
- LSD:
-
Least significant difference
- s.c.:
-
Subcutaneous
- STR:
-
Strychnine
- TST:
-
Tail suspension test
- 3α,5α-THP:
-
Allopregnanolone
- 3α-HSD:
-
3α-Hydroxysteroid dehydrogenase
- 5α-DHP:
-
5α-Dihydroprogesterone
References
Belzung C, Griebel G (2001) Measuring normal and pathological anxiety-like behaviour in mice: a review. Behav Brain Res 125:141–149
Boyer P (2000) Do anxiety and depression have a common pathophysiological mechanism? Acta Psychiatr Scand Suppl 102:24–29
Braida D, Capurro V, Zani A, Rubino T, Vigano D, Parolaro D, Sala M (2009) Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents. Br J Pharmacol 157:844–853
Chen Y, Dai TJ, Zeng YM (2007) Strychnine-sensitive glycine receptors mediate the analgesic but not hypnotic effects of emulsified volatile anesthetics. Pharmacology 80:151–157
Clement Y, Joubert C, Kopp C, Lepicard EM, Venault P, Misslin R, Cadot M, Chapouthier G (2007) Anxiety in mice: a principal component analysis study. Neural Plast 2007
Costall B, Jones B, Kelly M, Naylor R, Tomkins D (1989) Exploration of mice in a black and white test box: validation as a model of anxiety. Pharmacol Biochem Behav 32:777–785
Dutt V, Dhar VJ, Sharma A (2010) Antianxiety activity of Gelsemium sempervirens. Pharm Biol 48:1091–1096
Eser D, Romeo E, Baghai TC, Di Michele F, Schule C, Pasini A, Zwanzger P, Padberg F, Rupprecht R (2006) Neuroactive steroids as modulators of depression and anxiety. Neuroscience 138:1041–1048
Griebel G, Belzung C, Misslin R, Vogel E (1993) The free-exploratory paradigm: an effective method for measuring neophobic behaviour in mice and testing potential neophobia-reducing drugs. Behav Pharmacol 4:637–644
Haller J, Alicki M (2012) Current animal models of anxiety, anxiety disorders, and anxiolytic drugs. Curr Opin Psychiatry 25:59–64
Hattesohl M, Feistel B, Sievers H, Lehnfeld R, Hegger M, Winterhoff H (2008) Extracts of Valeriana officinalis L. s.l. show anxiolytic and antidepressant effects but neither sedative nor myorelaxant properties. Phytomedicine 15:2–15
Holladay JW, Dewey MJ, Yoo SD (1998) Pharmacokinetics and antidepressant activity of fluoxetine in transgenic mice with elevated serum alpha-1-acid glycoprotein levels. Drug Metab Dispos 26:20–24
Huang ZY, Liu M, Shen J, Su YP, Xu Y, Yu CX (2010) The anti-chronic pain effect of gelsevirine. Chin Tradit Herb Drugs 41:2034–2037
Kothari S, Minda M, Tonpay SD (2010) Anxiolytic and antidepressant activities of methanol extract of Aegle marmelos leaves in mice. Indian J Physiol Pharmacol 54:318–328
Kraft K (2011) Phytotherapy for psychosomatic diseases. MMW Fortschr Med 153:35–37
Laursen SE, Belknap JK (1986) Intracerebroventricular injections in mice. Some methodological refinements. J Pharmacol Methods 16:355–357
Lister RG (1987) The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92:180–185
Liu M, Shen J, Liu H, Xu Y, Su YP, Yang J, Yu CX (2011) Gelsenicine from Gelsemium elegans attenuates neuropathic and inflammatory pain in mice. Biol Pharm Bull 34:1877–1880
Magnani P, Conforti A, Zanolin E, Marzotto M, Bellavite P (2010) Dose–effect study of Gelsemium sempervirens in high dilutions on anxiety-related responses in mice. Psychopharmacology 210:533–545
Majewska MD (1992) Neurosteroids: endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance. Prog Neurobiol 38:379–395
Micale V, Cristino L, Tamburella A, Petrosino S, Leggio GM, Drago F, Di Marzo V (2009) Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels. Neuropsychopharmacology 34:593–606
Ossenkopp KP, Macrae LK, Teskey GC (1987) Automated multivariate measurement of spontaneous motor activity in mice: time course and reliabilities of the behavioral measures. Pharmacol Biochem Behav 27:565–568
Paul SM, Purdy RH (1992) Neuroactive steroids. FASEB J 6:2311–2322
Porsolt R, Le Pichon M, Jalfre M (1977) Depression: a new animal model sensitive to antidepressant treatments. Nature 266:730–732
Ramos A (2008) Animal models of anxiety: do I need multiple tests? Trends Pharmacol Sci 29:493–498
Rupprecht R, di Michele F, Hermann B, Ströhle A, Lancel M, Romeo E, Holsboer F (2001) Neuroactive steroids: molecular mechanisms of action and implications for neuropsychopharmacology. Brain Res Brain Res Rev 37:59–67
Shen J, Su YP, Xu Y, Liu H, Liu M, Yu CX (2009) Isolation and purification of gelsenicine and gelsevirine from Gelsemium elegans by high-speed counter-current chromatography. Chin Tradit Herb Drugs 40:1392–1395
Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85:367–370
Su YP, Shen J, Xu Y, Zheng M, Yu CX (2011) Preparative separation of alkaloids from Gelsemium elegans Benth. using pH-zone-refining counter-current chromatography. J Chromatogr A 1218:3695–3698
Svenningsson P, Tzavara ET, Qi H, Carruthers R, Witkin JM, Nomikos GG, Greengard P (2007) Biochemical and behavioral evidence for antidepressant-like effects of 5-HT6 receptor stimulation. J Neurosci 27:4201–4209
Venard C, Boujedaini N, Belon P, Mensah-Nyagan AG, Patte-Mensah C (2008) Regulation of neurosteroid allopregnanolone biosynthesis in the rat spinal cord by glycine and the alkaloidal analogs strychnine and gelsemine. Neuroscience 153:154–161
Venard C, Boujedaini N, Mensah-Nyagan AG, Patte-Mensah C (2009) Comparative analysis of gelsemine and Gelsemium sempervirens activity on neurosteroid allopregnanolone formation in the spinal cord and limbic system. Evid Based Complement Altern Med. doi:10.1093/ecam/nep083
Walf AA, Frye CA (2007) The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc 2:322–328
Xu Y, Qiu HQ, Liu H, Liu M, Huang ZY, Yang J, Su YP, Yu CX (2012) Effects of koumine, an alkaloid of Gelsemium elegans Benth., on inflammatory and neuropathic pain models and possible mechanism with allopregnanolone. Pharmacol Biochem Behav 101:504–514
Yan HC, Cao X, Das M, Zhu XH, Gao TM (2010) Behavioral animal models of depression. Neurosci Bull 26:327–337
Acknowledgments
This work was supported by the National Natural Science Foundation of China (No. 81173046, No. 30973520), the Key Program of Scientific Research of Fujian Medical University (No. ZD009), and the Exploitation Program of Industrial Technology of Fujian Development and Reform Commission of China ([2009] No. 958).
Conflict of interest
All authors have no potential conflicts of interest to declare.
Author information
Authors and Affiliations
Corresponding author
Additional information
Ming Liu and Hui-Hui Huang contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
Original data of elevated plus-maze, light–dark transition model, forced swim test, tail suspension test, spontaneous motor activity test, acute toxicity test, and strychnine antagonism test (PDF 742 kb)
Rights and permissions
About this article
Cite this article
Liu, M., Huang, HH., Yang, J. et al. The active alkaloids of Gelsemium elegans Benth. are potent anxiolytics. Psychopharmacology 225, 839–851 (2013). https://doi.org/10.1007/s00213-012-2867-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-012-2867-x